GOTEBORG, Sweden and
SAN FRANCISCO, Feb. 23, 2015 /PRNewswire/ -- Heliospectra AB
(OTCQB: HLSPY, FIRSTNORTH: HELIO), a world leader in intelligent
lighting technology for greenhouse cultivation and plant research,
today announced that it has hired Dr. Sue
Sisley as Director of Medicinal Plant Research.
As Director of Medicinal Plant Research at Heliospectra, Dr.
Sisley provides the company with "in the field" knowledge and
customer feedback. Working with growers to develop scalable
medicinal plant growing methodologies, Dr. Sisley oversees data
collection and reporting protocol with Heliospectra's medicinal
plant cultivators in the US, Canada and globally.
Dr. Sisley's research focuses on the use of medicinal cannabis
as an effective treatment option for veterans suffering from
chronic post-traumatic stress disorder. Directly in line with
Heliospectra's value to growers, Dr. Sisley is capable of helping
Heliospectra's customers understand what chemical profiles a
medicinal plant therapy should express.
"The light source offers the opportunity to build specific,
consistent medicinal plant therapies. I am proud to be associated
with such a talented company," Sisley said. "As the cannabis
industry matures, more growers will need to differentiate their
product—one way to do that is by supplying PTSD patients with the
type of medicine they know helps them live more productive
lives."
CBD is a vital research element for Dr. Sisley, who is both
a practicing physician and a clinical psychologist. "Heliospectra,
myself and several growers are involved with CBD rich strain and
other medicinal growing projects. Ironically and thankfully, the
market is light years ahead of government approval
processes—Heliospectra is a part of that cutting edge agriculture
movement."
"Heliospectra is proud to play an important role in Dr.
Sue Sisley's PTSD work," said
Staffan Hillberg, CEO of
Heliospectra. "Combining her groundbreaking research with
Heliospectra's world leading technology proves again how important
plants are to human therapy, especially when they can help people
live a normal, healthy life."
Dr. Sisley earned her BS in Chemistry and Pre-medicine at
Northern Arizona University. She
completed her medical degree at the University
of Arizona College of Medicine followed by a five-year
Residency Training at Good Samaritan Regional Medical Center in the
fields of Internal Medicine and Psychiatry. With the
Multidisciplinary Association for Psychedelic Studies, Dr. Sisley
was awarded a research grant to study the safety and efficacy of
marijuana as a treatment for post-traumatic stress disorder.
"Dr. Sue Sisley is an integral
part of our staff. Her research grant from the Colorado Board of Health to study the effects
of cannabis on those that suffer from PTSD underscores just how
important medicinal cannabis is to the market. Heliospectra will
continue to support veterans and others that suffer from such
debilitating ailments," said Chris
Walker, General Manager of Heliospectra. "As our
growers know, precision commercial operations start with the lamp -
light is one way to unlock the genetic instructions found in plants
and growing healthy, low carbon footprint medicine is the entire
industry's responsibility."
G&W Brokerage is the company's Certified Adviser –
www.gwkapital.se
Heliospectra AB, Box 5401, SE-402 29, Goteborg, Sweden
Heliospectra AB (publ - listed on NASDAQ OMX
First North HELIO ISIN SE0005933082 as well as North American
ADR OTCQB: HLSPY Cusip: 423281104)
Founded in 2006 and specializing in intelligent lighting technology
for plant research and greenhouse cultivation. Heliospectra
products are based on in-depth knowledge in plant
physiology and photosynthesis along with a unique way to
utilize modern LED technology. After six years of development in
Sweden, the company has now begun
to expand into the international market. The company has raised
more than $ 15 million in venture
capital and has received more than $2.6
million through academic scholarships and grants. It has
also received numerous awards for its forward thinking technology.
Principal owners: Industrial Fund
www.industrifonden.se, Midroc www.midroc.se;,
Weland Steel
www.welandstal.se; Wood & Hill Investment
www.woodhillinvestment.com.
Photo - http://photos.prnewswire.com/prnh/20150218/176399
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/heliospectra-ab-hires-dr-sue-sisley-as-director-of-medicinal-plant-research-300039451.html
SOURCE Heliospectra AB